Skip to main content
SpringerLink
Log in

Cytomegalovirus Infection

  • Chapter
  • First Online:
Neonatal Infections

  • 1359 Accesses

Abstract

Cytomegalovirus (CMV) is the leading cause of congenital infection in humans and constitutes a major public health problem. Congenitally infected infants, both symptomatic and asymptomatic at birth, are at risk for sequelae including sensorineural hearing loss. The virus can be transmitted to the fetus following either a primary or a non-primary maternal infection during pregnancy. Even though the transmission rate is much higher in primary infected mothers than in mothers with preconceptional immunity, routine CMV screening of pregnant women is not recommended today because no consensus exists on prenatal treatment options. Intravenous ganciclovir or oral valganciclovir are used to treat neonates with symptoms at birth. Valganciclovir treatment for 6 months is recommended for congenitally infected neonates with moderately to severely symptomatic disease. All infants with congenital CMV infection, both symptomatic and asymptomatic at birth, need a follow-up evaluation to detect sequelae promptly. For several years, a universal screening for congenital CMV infection has been suggested by many authors for early detection of sequelae and timely intervention. A real-time PCR assay of saliva specimens seems to offer the best characteristics for use in screening.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Plosa EJ, Esbenshade JC, Fuller MP, Weitkamp JH. Cytomegalovirus infection. Pediatr Rev. 2012;33:156–63.

    Article  PubMed  Google Scholar 

  2. Ross SA, Arora N, Novak Z, Fowler KB, Britt WJ, Boppana SB. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis. 2010;201:386–9.

    Article  PubMed  Google Scholar 

  3. Lanzieri TM, Kruszon-Moran D, Gambhir M, Bialek SR. Influence of parity and sexual history on cytomegalovirus seroprevalence among women aged 20-49 years in the USA. Int J Gynaecol Obstet. 2016;135:82–5.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis. 2010;50:1439–47.

    Article  PubMed  Google Scholar 

  5. Lanzieri TM, Dollard SC, Bialek SR, Grosse SD. Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis. 2014;22:44–8.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cannon MJ, Stowell JD, Clark R, et al. Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children. BMC Infect Dis. 2014;14:569.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hyde TB, Schmid DS, Cannon MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol. 2010;20:311–26.

    Article  PubMed  Google Scholar 

  8. Cantey JB, Sanchez PJ. Overview of congenital infections: the prominence of cytomegalovirus. Infect Disord Drug Targets. 2011;11:426–31.

    Article  CAS  PubMed  Google Scholar 

  9. Boppana SB, Ross SA, Shimamura M, et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364:2111–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26:86–102.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Josephson CD, Caliendo AM, Easley KA, et al. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study. JAMA Pediatr. 2014;168:1054–62.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kagan KO, Hamprecht K. Cytomegalovirus infection in pregnancy. Arch Gynecol Obstet. 2017;296:15–26.

    Article  PubMed  Google Scholar 

  13. Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013;57:S178–81.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J. 1992;11:93–9.

    Article  CAS  PubMed  Google Scholar 

  15. Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17:177–88.

    Article  Google Scholar 

  16. Fowler KB, McCollister FP, Dahle AJ, et al. Progressive and fluctuating sensorineural hearing loss in infants with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997;130:624–30.

    Article  CAS  PubMed  Google Scholar 

  17. Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134:972–82.

    Article  PubMed  Google Scholar 

  18. Kenna MA. Acquired hearing loss in children. Otolaryngol Clin N Am. 2015;48:933–53.

    Article  Google Scholar 

  19. Fowler KB. Congenital cytomegalovirus infection: audiologic outcome. Clin Infect Dis. 2013;57:S182–4.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Gunkel J, de Vries LS, Johngmans M, et al. Outcome of preterm infants with postnatal cytomegalovirus infection. Pediatrics. 2018;141:e20170635.

    Article  PubMed  Google Scholar 

  21. Mosca F, Pugni L. Cytomegalovirus infection: the state of the art. J Chemother. 2007;19:46–8.

    Article  PubMed  Google Scholar 

  22. Kaneko M, Ohhashi M, Minematsu T, Muraoka J, Kusumoto K, Sameshima H. Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection. J Infect Chemother. 2017;23:173–6.

    Article  PubMed  CAS  Google Scholar 

  23. Goegebuer T, Van Meensel B, Beuselinck K, et al. Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples. J Clin Microbiol. 2009;47:660–5.

    Article  PubMed  CAS  Google Scholar 

  24. Stehel EK, Shoup AG, Owen KE, et al. Newborn hearing screening and detection of congenital cytomegalovirus infection. Pediatrics. 2008;121(5):970.

    Article  PubMed  Google Scholar 

  25. Duryea EL, Sanchez PJ, Sheffield JS, et al. Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus. Pediatr Infect Dis J. 2010;29:915–8.

    Article  PubMed  Google Scholar 

  26. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005;353:1350–62.

    Article  PubMed  CAS  Google Scholar 

  27. Revello MG, Lazzarotto T, Guerra B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med. 2014;370:1316–26.

    Article  PubMed  CAS  Google Scholar 

  28. Kimberlin DW, Jester PM, Sánchez PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015;372:933–43.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Kimberlin DW, Lin CY, Sánchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16–25.

    Article  PubMed  CAS  Google Scholar 

  30. Lim Y, Lyall H. Congenital cytomegalovirus – who, when, what-with, and why to treat? J Infect. 2017;74:S89–94.

    Article  PubMed  Google Scholar 

  31. Gunkel J, Wolfs TF, de Vries LS, Nijman J. Predictors of severity for postnatal cytomegalovirus infection in preterm infants and implications for treatment. Expert Rev Anti-Infect Ther. 2014;12:1345–55.

    Article  PubMed  CAS  Google Scholar 

  32. Schleiss MR, Permar SR, Plotkin SA. Progress toward development of a vaccine against congenital cytomegalovirus infection. Clin Vaccine Immunol. 2017;24:e00268-17.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Jeon J, Victor M, Adler SP, et al. Knowledge and awareness of congenital cytomegalovirus among women. Infect Dis Obstet Gynecol. 2006;2006:80383.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Vauloup-Fellous C, Picone O, Cordier AG, et al. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol. 2009;46:S49–53.

    Article  PubMed  Google Scholar 

  35. Hamprecht K, Goelz R. Postnatal cytomegalovirus infection through human milk in preterm infants: transmission, clinical presentation, and prevention. Clin Perinatol. 2017;44:121–30.

    Article  PubMed  Google Scholar 

  36. American Academy of Pediatrics, Policy Statement. Breastfeeding and the use of human milk. Pediatrics. 2012;129:827–41.

    Article  Google Scholar 

  37. Amir J, Schwarz M, Levy I, Haimi-Cohen Y, Pardo J. Is lenticulostriated vasculopathy a sign of central nervous system insult in infants with congenital CMV infection? Arch Dis Child. 2011;96:846–50.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neonatal Intensive Care Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy

    Andrea Ronchi MD, Lorenza Pugni MD & Fabio Mosca MD

Authors
  1. Andrea Ronchi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lorenza Pugni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fabio Mosca MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Ronchi MD .

Editor information

Editors and Affiliations

  1. University of Texas Health Science Center San Antonio, San Antonio, Texas, USA

    Joseph B. Cantey

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ronchi, A., Pugni, L., Mosca, F. (2018). Cytomegalovirus Infection. In: Cantey, J. (eds) Neonatal Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-90038-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90038-4_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90037-7

  • Online ISBN: 978-3-319-90038-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation